India gives final urgent-use approval to AstraZeneca and local Covid vaccines
[NEW DELHI] The head of India's drugs regulator said on Sunday he had given final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
The overall efficacy of the AstraZeneca/Oxford vaccine was 70.42 per cent, while Bharat Biotech's Covaxin was "safe and provides a robust immune response", Drugs Controller General of India VG Somani said.
The British-developed AstraZeneca/Oxford shot is being made locally by the Serum Institute of India, while Bharat Biotech has teamed up with the government-run Indian Council of Medical Research.
"Vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situations," Mr Somani read out from a written statement at a press conference. Mr Somani did not take questions.
Prime Minister Narendra Modi welcomed the approvals.
"It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India!" he said on Twitter, calling it a sign of a "self-reliant" country.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Fed survey cites inflation, US election as key financial stability risks
Oil prices steady after Iran plays down reported Israeli attack
G7 pledges swift aid for Ukraine, seeks to calm Middle East
H5N1 strain of bird flu found in milk: WHO
China moves to boost foreign investment in domestic tech companies
Xi orders China’s biggest military reorganisation since 2015